Depression Clinical Trial
Official title:
Sleep-wake Rhythm in the Perioperative Period in Patients Admitted for Elective Radical Surgery for Colorectal Cancer: an Observational Prospective Cohort Study.
Verified date | January 2019 |
Source | Zealand University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational [Patient Registry] |
Objective The objective of the current trial is to investigate the effect of perioperative
sleep and circadian rhythm on the natural course of survival among patient diagnosed with
colorectal cancer. Concurrently, outcome measures like depression, fatigue, quality of life,
and co-morbidity will be measured continuously in the short-, intermediate- and long-term
period following diagnosis.
The a-priori hypothesis is that preoperative sleep and circadian disturbances is a prognostic
marker of reduced overall survival. Likewise, preoperative sleep-wake disturbances at
baseline are expected to result in overall universally reduced quality of life, increased
depression and fatigue. Furthermore, development of sleep-wake disturbances in the
postoperative period as compared to preoperative sleep-wake rhythm is expected to a
prognostic marker of negative outcomes.
Target and study population The study population are all patients diagnosed with colorectal
cancer in Region Zealand recruited consecutively from the trial initiation until study end
each patient with an intended 5 year follow-up period. All available cases will be included
in the trial.
Study design The study will be an observational prospective cohort study applying a
longituditional repeated measure design.
Exposures and outcomes of interest The primary outcomes in the trial are sleep and circadian
outcomes measured via actigraphy in the perioperative period.
Furthermore, cancer related survival and overall survival in the 5 year follow-up period is
considered primary outcomes.
Secondary outcomes consist of consecutively measured depression, fatigue, quality of life,
follow-up treatment and co-morbidity.
Exposure variables are primary related to the cancer, i.e. cancer stage, surgical treatment,
oncological treatment, baseline co-morbidity and pharmacological treatment. Some of the
secondary outcomes could be expected to serve as confounding or mediating factors.
Meaningful control for confounding will in the analysis phase be cancer stage and baseline
sleep-wake rhythm status.
Sampling methods All available cases will be sought included in the trial. No formal sample
size has been performed and continues inclusion into the trial will be performed during an
1,5 year period.
Statistical analyses The relationship between overall survival and baseline sleep-wake rhythm
will be investigated using survival statistics and/or multivariate logistic regression.
Expected results The investigators expect to see a marked difference in overall survival
among patients with sleep and circadian disturbances at baseline.
Status | Active, not recruiting |
Enrollment | 45 |
Est. completion date | July 31, 2023 |
Est. primary completion date | July 31, 2018 |
Accepts healthy volunteers | |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Diagnosis of colorectal cancer as determined at the multi-disciplinary team conference. - Admitted to elective radical surgery at the department of surgery at Zealand University Hospital - Age above 18 years - Informed consent Exclusion Criteria: - Non-ability to complete the study as assessed by the investigator - Non-fluent in Danish. - History of cognitive impairment (e.g. dementia) - Paralysis or inability to answer study questioners electronically. - Stadium 4 colonic adenocarcinoma with no surgical treatment options as determined at the multi-disciplinary conference. |
Country | Name | City | State |
---|---|---|---|
Denmark | Department of Surgery, Zealand University Hospital | Roskilde | Zealand |
Lead Sponsor | Collaborator |
---|---|
Zealand University Hospital | Center of Surgical Science, Department of Surgery, Zealand University Hospital |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Actigraphy | Assessment of activity using accelerometor - Sleep and circadian assesment. | Approximately 1 week preoperatively to 2 weeks postoperatively | |
Secondary | Major Depression Inventory | Assesment of depression | Baseline (approx. 1 week preoperatively), 2 weeks postoperatively, 3 months postoperatively, 6 months postoperatively, 12 months postoperativly, 24 months postoperatively, 36 months postoperatively, 60 months postoperatively. | |
Secondary | Insomnia Severity Index | Subjective sleep assesment | Baseline (approx. 1 week preoperatively), 2 weeks postoperatively, 3 months postoperatively, 6 months postoperatively, 12 months postoperativly, 24 months postoperatively, 36 months postoperatively, 60 months postoperatively. | |
Secondary | Quality of life assesment | EORCT-QLQ-C30 | Baseline (approx. 1 week preoperatively), 2 weeks postoperatively, 3 months postoperatively, 6 months postoperatively, 12 months postoperativly, 24 months postoperatively, 36 months postoperatively, 60 months postoperatively. | |
Secondary | Quality of life assesment | EORCT-QLQ-CR29 | Baseline (approx. 1 week preoperatively), 2 weeks postoperatively, 3 months postoperatively, 6 months postoperatively, 12 months postoperativly, 24 months postoperatively, 36 months postoperatively, 60 months postoperatively. | |
Secondary | Mortality | Baseline registration and follow-up assessments | Baseline (approx. 1 week preoperatively), 2 weeks postoperatively, 3 months postoperatively, 6 months postoperatively, 12 months postoperativly, 24 months postoperatively, 36 months postoperatively, 60 months postoperatively. | |
Secondary | Co-morbidity | Baseline registration and follow-up assessments | Baseline (approx. 1 week preoperatively), 2 weeks postoperatively, 3 months postoperatively, 6 months postoperatively, 12 months postoperativly, 24 months postoperatively, 36 months postoperatively, 60 months postoperatively. | |
Secondary | Drug prescription history (Drug name and dosage) | Baseline registration and follow-up assessments | Baseline (approx. 1 week preoperatively), 2 weeks postoperatively, 3 months postoperatively, 6 months postoperatively, 12 months postoperativly, 24 months postoperatively, 36 months postoperatively, 60 months postoperatively. | |
Secondary | Follow-up cancer treatment (Adjuvant chemotherapy, timing and duration) | Baseline registration and follow-up assessments | Baseline (approx. 1 week preoperatively), 2 weeks postoperatively, 3 months postoperatively, 6 months postoperatively, 12 months postoperativly, 24 months postoperatively, 36 months postoperatively, 60 months postoperatively. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05777044 -
The Effect of Hatha Yoga on Mental Health
|
N/A | |
Recruiting |
NCT04680611 -
Severe Asthma, MepolizumaB and Affect: SAMBA Study
|
||
Recruiting |
NCT04977232 -
Adjunctive Game Intervention for Anhedonia in MDD Patients
|
N/A | |
Recruiting |
NCT04043052 -
Mobile Technologies and Post-stroke Depression
|
N/A | |
Completed |
NCT04512768 -
Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy
|
N/A | |
Recruiting |
NCT03207828 -
Testing Interventions for Patients With Fibromyalgia and Depression
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Completed |
NCT04476446 -
An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives
|
Phase 3 | |
Recruiting |
NCT02783430 -
Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease
|
Phase 2/Phase 3 | |
Recruiting |
NCT05563805 -
Exploring Virtual Reality Adventure Training Exergaming
|
N/A | |
Completed |
NCT04598165 -
Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support
|
N/A | |
Completed |
NCT03457714 -
Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
|
||
Recruiting |
NCT05956912 -
Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
|
||
Completed |
NCT05588622 -
Meru Health Program for Cancer Patients With Depression and Anxiety
|
N/A | |
Recruiting |
NCT05234476 -
Behavioral Activation Plus Savoring for University Students
|
N/A | |
Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
Enrolling by invitation |
NCT03276585 -
Night in Japan Home Sleep Monitoring Study
|
||
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Terminated |
NCT03275571 -
HIV, Computerized Depression Therapy & Cognition
|
N/A |